View Older Stories View More Recent Stories

Mar 7, 2019 08:30AM VolitionRx Limited Schedules Full Year 2018 Earnings Conference Call and Business Update
Nov 7, 2018 04:05PM VolitionRx Limited Announces Third Quarter 2018 Financial Results and Business Update
Oct 31, 2018 04:30PM VolitionRx Limited Schedules Third Quarter 2018 Earnings Conference Call and Business Update
Oct 4, 2018 09:00AM VolitionRx Limited to Expand its Nu.Q(TM) Trials to Veterinary Diagnostics
Sep 26, 2018 09:00AM VolitionRx Limited Releases Video Featuring Interviews with its Scientific Advisory Board
Sep 5, 2018 08:30AM VolitionRx Limited to Attend Multiple Conferences in September
Aug 13, 2018 04:05PM VolitionRx Limited Announces Second Quarter 2018 Financial Results and Business Update
Aug 13, 2018 08:36AM Volitionrx (VNRX) Says Preliminary Data from Study Demonstrates 94% Accuracy in Detecting Aggressive Prostate Cancer
Aug 13, 2018 08:30AM Preliminary Data from Study Demonstrates 94% Accuracy in Detecting Aggressive Prostate Cancer
Aug 9, 2018 08:30AM VolitionRx Limited Announces Completion of Sample Collection in Endometriosis Study
Aug 8, 2018 06:00AM VolitionRx Announces $9 Million Private Placement
Aug 7, 2018 08:35AM VolitionRx Limited Schedules Second Quarter 2018 Earnings Conference Call and Business Update
Aug 1, 2018 07:00AM VolitionRx's First Research Use Only Product Is "On-The-Shelf" Today
Jul 10, 2018 08:30AM Volition Extends Global Reach of its Clinical Trial Program
Jul 2, 2018 08:30AM Volition Secures Additional $700,000 Non-Dilutive Funding from the Walloon Region
May 14, 2018 09:00AM VolitionRx Limited to Attend the Bank of America Merrill Lynch 2018 Health Care Conference from May 15-17, 2018
May 10, 2018 04:05PM VolitionRx Limited Announces First Quarter 2018 Financial Results and Business Update
May 9, 2018 09:00AM VolitionRx Signs a Global Sales and Distribution Agreement with Active Motif for its new RUO kits
May 4, 2018 08:00AM VolitionRx Limited Schedules First Quarter 2018 Earnings Conference Call and Business Update
Mar 13, 2018 04:05PM VolitionRx Announces Closing of $8.4 Million Public Offering of Common Stock
Mar 9, 2018 09:12AM Volitionrx Limited (VNRX) Prices 3.5M Common Stock Offeirng at $2.40/Share
Mar 9, 2018 09:10AM VolitionRx Announces Pricing of $8.4 Million Public Offering of Common Stock
Mar 8, 2018 06:06PM Volitionrx Limited (VNRX) to Offer Common Stock
Mar 8, 2018 04:01PM VolitionRx Announces Proposed Underwritten Public Offering of Common Stock
Mar 7, 2018 08:30AM VolitionRx Appoints Harvard Professor, Dr. Lee-Jen Wei to Its Scientific Advisory Board
Mar 1, 2018 04:05PM VolitionRX Limited Announces Full Fiscal Year 2017 Financial Results and Business Update
Feb 28, 2018 04:05PM VolitionRx Limited Schedules Full Year 2017 Earnings Conference Call and Business Update
Feb 26, 2018 04:05PM VolitionRx Limited Announces Interim Results from 680-Subject Clinical Trial in Colorectal Cancer
Feb 5, 2018 08:30AM VolitionRX Announces the Successful Conclusion of the Logistics and Pathway Design Study Conducted in Denmark.
Jan 3, 2018 08:30AM VolitionRx Limited Releases Letter to Shareholders Including Status Update on Key Clinical Milestone
Dec 5, 2017 07:30AM VolitionRx Limited to Attend Conferences in December
Nov 10, 2017 07:30AM Singapore Volition signs Memorandum of Understanding with the National Taiwan University to Conduct Two Large Clinical Studies
Nov 9, 2017 04:05PM VolitionRx Limited Announces Third Quarter 2017 Financial Results and Business Update
Nov 2, 2017 08:30AM VolitionRx Limited Schedules Third Quarter 2017 Earnings Conference Call and Business Update
Sep 22, 2017 08:30AM VolitionRx Announces the Initial Sale of its New Nu.Q(TM) Research Kits
Sep 21, 2017 04:30PM VolitionRx Limited Awarded $1.5 Million in Non-Dilutive Funding
Sep 19, 2017 04:30PM VolitionRx Announces its European Colorectal Cancer Strategy
Sep 15, 2017 07:30AM VolitionRx to Attend Two Major Conferences in Asia
Sep 14, 2017 08:00AM Volition Granted Four Additional Patents
Sep 6, 2017 04:30PM VolitionRx Limited to Attend Multiple Conferences in September
Aug 22, 2017 04:30PM Volition Signs Agreement with the Institute of Laboratory Medicine of the Technical University of Munich, Germany, to assist in securing large trials in a range of cancers
Aug 9, 2017 04:05PM VolitionRx Limited Announces Second Quarter 2017 Financial Results and Business Update
Aug 3, 2017 04:30PM VolitionRx Limited Schedules Second Quarter 2017 Earnings Conference Call and Business Update
Jul 19, 2017 04:30PM VolitionRx Limited to host a conference call regarding a 13,500 Subject Colorectal Cancer Screening Trial with the Early Detection Research Network of the U.S. National Cancer Institute
Jul 18, 2017 06:30AM Volition America, Inc. Announces a Colorectal Cancer Screening Trial containing approximately 13,500 Subjects in Collaboration with the Early Detection Research Network of the U.S. National Cancer Ins
Jun 30, 2017 09:22AM Volition to Present at the EuropaColon Advocacy Masterclass and Exhibit at the European Society for Medical Oncology Gastrointestinal Cancer Congress
Jun 27, 2017 07:30AM VolitionRx Limited Corrects an Earlier Announcement
May 26, 2017 06:30AM VolitionRx Limited to Present at Multiple Investor Conferences in June
May 18, 2017 09:00AM A new publication reports that 91% of colorectal cancers were detected at 90% specificity in a completed prospective trial using Volition's Nu.Q(TM) assays
May 11, 2017 06:30AM VolitionRx Limited Announces First Quarter 2017 Financial Results and Business Update
View More Recent Stories View Older Stories